Text Size

Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00792896
First received: November 16, 2008
Last updated: November 17, 2008
Last verified: May 2008
History of Changes
  Purpose

Family usually had a lot of burden to tell the truth to patients. The purpose of this study is to assess the effect of education materials and family conference for advanced cancer patients and family.


Condition Intervention
Advanced Cancer
Metastatic Cancer
 Behavioral: family conference

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: A Longitudinal Study That Assessed the Effectiveness of Intervention Toward

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Questionnaires [ Time Frame: before and 1 week after the intervention ] [ Designated as safety issue: No ]

Estimated Enrollment: 150
Study Start Date: May 2008
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Family conference + education materials
 Behavioral: family conference
family conference
No Intervention: 2
education materials

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • advanced or metastatic cancer patients
  • more than 20 years old
  • clear consciousness and be able to communicate

Exclusion Criteria:

  • refuse to know the statement of himself/herself disease
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00792896

Contacts
Contact: We-Yu Hu, Ph.D 23123456 ext 88428 weyuhu@ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: We-Yu Hu, Ph.D     23123456 ext 88428     weyuhu@ntu.edu.tw    
Principal Investigator: We-Yu Hu, Ph.D            
Sponsors and Collaborators
National Taiwan University Hospital
National Science Council, Taiwan
  More Information

No publications provided

Responsible Party: 1, Jen-Ai Road Section 1, Taipei, Taiwan, Department of Nursing
ClinicalTrials.gov Identifier: NCT00792896     History of Changes
Other Study ID Numbers: 200803051R
Study First Received: November 16, 2008
Last Updated: November 17, 2008
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
Neoplastic Processes
Pathologic Processes

ClinicalTrials.gov processed this record on May 21, 2013